Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 102Neoplasm Metastasis 26Neoplasms 15Brain Neoplasms 13Prostatic Neoplasms 10Endometrial Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Ovarian Neoplasms 7Glioblastoma 7Glioma 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Head and Neck Neoplasms 5Colorectal Neoplasms 5Breast Diseases 5Sarcoma 4Recurrence 4Pancreatic Neoplasms 4Lymphoma, Non-Hodgkin 4Sarcoma, Ewing 3Osteosarcoma 3Neoplasms by Site 3Multiple Myeloma 3Meningioma 3Melanoma 3Liposarcoma 3Carcinoma, Renal Cell 3Unilateral Breast Neoplasms 2Rhabdomyosarcoma 2Rhabdoid Tumor 2

Interventions

Doxorubicin 16Zidovudine 13Vincristine 12Bleomycin 11Interferon alpha-2 6Cyclophosphamide 6Methotrexate 5Liposomes 5Leucovorin 5Dexamethasone 5tecogalan 4sargramostim 4Filgrastim 4Etoposide 4Cytarabine 4Ritonavir 3Nivolumab 3Fluorouracil 3pomalidomide 2liposomal doxorubicin 2interferon alfa-n1 2Watchful Waiting 2Valganciclovir 2Tumor Necrosis Factor-alpha 2Tobacco Use Cessation Devices 2Thalidomide 2Surveys and Questionnaires 2Rituximab 2Paclitaxel 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × abemaciclib × Clear all
NCT04941274 2026-05-05

Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
111 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡